BioSenic SA
The score of BioSenic shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -94 %
Accounts of the company itself (not consolidated). Consolidated group accounts are also filed: they are in the full file.
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
BioSenic's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jul 2026
- Year ended 31 Dec 2024filed on 01 Dec 2025
- Year ended 31 Dec 2023filed on 16 Jul 2024
- Year ended 31 Dec 2022filed on 05 Jul 2023
- Year ended 31 Dec 2021filed on 20 Jun 2022
BioSenic's financial analysis
- Solvency-19.5%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of BioSenic
BioSenic's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0882.015.654
- VAT number
- BE0882015654
- Peppol
- Registered · 0208:0882015654 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 22 Jun 2006
- Registered office
- 1480 Tubize
- Latest accounts
- 2025 · filed on 02 Jul 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
BioSenic (SA) has been based in Tubize since 2006, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net profit of €22.2m and equity of −661,415 €; its revenue is not published. Its solvency stands at -19.5%, below the median of its sector (58.2%).
Companies similar to BioSenic
Companies in the same business, of comparable size and area, outside its group.
- Alanine Research and experimental development on natural sciences and engineering Lasne · balance sheet 28,321 €
- IQVIA Cancer Research Research and experimental development on natural sciences and engineering Zaventem · balance sheet €1.07m
- Bimsconsult Research and experimental development on natural sciences and engineering Auderghem · balance sheet 463,296 €
- Innovation Facilities Research and experimental development on natural sciences and engineering Nivelles · balance sheet €3.30m
- De Winter - Winne Research and experimental development on natural sciences and engineering Deinze · balance sheet €2.92m
- Eurec Research and experimental development on natural sciences and engineering Ixelles · balance sheet €2.59m
- Glibert Bart Research and experimental development on natural sciences and engineering Ronse · balance sheet €2.59m
- Dr. Coppens Greet, oogarts Research and experimental development on natural sciences and engineering Aalst · balance sheet €2.37m
Frequently asked questions about BioSenic
What is the revenue of BioSenic?
BioSenic files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of BioSenic?
In Belgium, the VAT number is the company number prefixed with BE: BE0882015654 for BioSenic, if the company is VAT-registered. Its company number (CBE) is 0882.015.654.
Where is the registered office of BioSenic?
According to the CBE register, the registered office of BioSenic is in 1480 Tubize.
What is the equity of BioSenic?
At the close of the 2025 financial year, the equity of BioSenic amounts to -661,415 €, a solvency of -19.5% of total assets.
Who manages BioSenic?
The register lists 10 active mandates at BioSenic. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of BioSenic
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →